Equate Cool and Heat Pain Relieving Liquid

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of minor muscle and joint pain associated with conditions such as arthritis, simple backache, muscle strains, sprains, and bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 12 years of age, the recommended application is to the affected area no more than 3 to 4 times daily. It is important to ensure that the medicine does not come into contact with the hands; if contact occurs, hands should be washed thoroughly with soap and water.

For children 12 years of age or younger, it is advised to consult a physician before use.

Contraindications

There are no contraindications associated with the use of this product. It is deemed safe for use in the absence of specific conditions or situations that would warrant avoidance.

Warnings and Precautions

When using this product, it is imperative to adhere strictly to the directions provided. Healthcare professionals should advise patients against tightly bandaging the treated area or using heating pads in conjunction with the product, as these practices may exacerbate adverse effects.

Contact with the eyes and mucous membranes must be avoided to prevent irritation. The product should not be applied to wounds or any damaged, broken, or irritated skin, as this may lead to further complications.

Patients may experience a temporary burning sensation following application; however, this sensation typically resolves within several days. Should a severe burning sensation occur, it is crucial to discontinue use immediately. In cases where swelling or blistering of the skin is observed, patients should cease application and seek medical attention without delay.

Additionally, it is essential to instruct patients to avoid exposing the treated area to heat or direct sunlight, as this may increase the risk of adverse reactions. In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted for guidance.

Side Effects

Patients may experience a temporary burning sensation following the use of the product; this sensation typically resolves within several days. In the event of a severe burning sensation, it is advised to discontinue use immediately. Additionally, if patients notice swelling or blistering of the skin, they should stop using the product and seek medical attention promptly.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions between this drug and laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Cool and Heat Pain Relieving Liquid (cool and heat pain relief). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients over 12 years of age may apply the medication to the affected area no more than 3 to 4 times daily. For children 12 years or younger, it is advised to consult a doctor before use. Care should be taken to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully considered in these populations to ensure the safety of both the mother and the fetus or infant.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the potential risks and benefits.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from excessive dosing. Symptoms of overdosage can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively. Additionally, healthcare professionals should refer to local protocols and guidelines for the management of overdose situations, as these may provide specific recommendations based on the substance involved.

Overall, vigilance and prompt intervention are critical in managing any suspected overdosage scenario.

Nonclinical Toxicology

If pregnant or breastfeeding, it is advised to consult a healthcare professional prior to use. No non-teratogenic effects have been specified in the available data. Additionally, there are no details provided regarding nonclinical toxicology or animal pharmacology and toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This precaution is crucial to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in a configuration that ensures optimal safety and efficacy. It is essential to keep the product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

For storage, the treated area should not be exposed to heat or direct sunlight, as these conditions may compromise the integrity of the product. Proper handling and storage are crucial to maintain the product's effectiveness and safety.

Additional Clinical Information

The medication is administered topically, with a recommended application frequency of no more than 3 to 4 times daily for adults and children over 12 years of age. Clinicians should advise patients to wash their hands with soap and water if the medicine comes into contact with them.

Patients who are pregnant or breastfeeding should consult a healthcare professional prior to use. It is important to keep the medication out of reach of children, and in the event of ingestion, medical assistance or contact with a Poison Control Center is necessary.

Drug Information (PDF)

This file contains official product information for Equate Cool and Heat Pain Relieving Liquid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)